Clinical Trials Sponsored by Axel Brandes

Total 1213 results

Adel Mohamed
Health Sciences Centre, Winnipeg, Manitoba; Mount Sinai Hospital, Canada

Completed

Lung Ultrasound for Prediction of Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia (BPD)

Canada
Adel Helmy
Cambridge University Hospitals NHS Foundation Trust

Unknown

IL-1ra Dose-range Study for Moderate-to-severe TBI Patients (IL1ra)

Traumatic Brain INjury

United Kingdom
University of South Alabama
Amerifit Brands Inc

Completed

Probiotics For The Prevention of Antibiotics Associated Diarrhea in the Pediatric Intensive Care Unit

Critical Illness | Antibiotic-associated Diarrhea
Grande International Hospital, Nepal

Completed

Optic Nerve Course Variants in Nepali Population (ONC)

Optic Nerve

Nepal
Barnes Retina Institute
Novartis

Completed

Use of Spectral OCT in Combination Therapy (Spectral OCT)

Choroidal Neovascularization
Barnes Retina Institute
Allergan

Terminated

Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane (OZURDEX2)

Macular Edema | Epiretinal Membrane

United States
Barnes Retina Institute
Pfizer

Terminated

Macugen for Histoplasmosis

Choroidal Neovascularization | Ocular Histoplasmosis

United States
Sohag University
Randers Regional Hospital

Recruiting

Oral Versus Intravenous Antibiotic Prophylaxis Before Obstetric and Gynecological Procedures

Site Infection

Egypt
Teva Branded Pharmaceutical Products R&D, Inc.
Parexel

Completed

A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)

Asthma

United States
Shandong Branden Med.Device Co.,Ltd
Shanghai Zhongshan Hospital

Unknown

CathiportTM Clinical Efficacy and Safety Evaluation

Cancer
Teva Branded Pharmaceutical Products R&D, Inc.
PPD

Completed

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Asthma

United States, Bulgaria, Croatia, Hungary, Israel, Poland, Serbia, Spain, Ukraine
Cephalon

Completed

Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk Herniation

Sciatica

United States, Australia
Cephalon

Completed

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Depression

United States, Argentina, Brazil, Bulgaria, Croatia, Finland, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Ukraine
Cephalon

Completed

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Depression

United States
Cephalon

Terminated

Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy

Multiple Myeloma

United States
Brandeis University
National Institute on Drug Abuse (NIDA)

Completed

Enhancing Early-Phase Care for Primary Care Patients With Unhealthy Substance Use

Substance Use Disorders

United States
Cephalon

Terminated

Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)

Multiple Myeloma

United States
Cephalon

Terminated

Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women

Osteoporosis | Bone Loss

Australia
Cephalon

Completed

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Sleep Apnea, Obstructive | Narcolepsy

United States, Canada
Cephalon

Completed

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome

Sleep Apnea, Obstructive

United States, Canada
Cephalon

Completed

Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment

Attention Deficit Hyperactivity Disorder

United States
Cephalon

Completed

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

Cancer | Breakthrough Pain

United States, Puerto Rico
Cephalon

Completed

Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States, Canada
Cephalon

Completed

A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

Anxiety Disorder

United States, Canada
Cephalon

Completed

Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy

Narcolepsy
Cephalon

Completed

Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness

Narcolepsy | Excessive Daytime Sleepiness | Chronic Shift Work Sleep Disorder | Obstructive Sleep Apnea/Hypopnea Syndrome

United States, Australia, Canada, France, Puerto Rico, Germany, Russian Federation
Cephalon

Completed

Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance

Excessive Sleepiness

United States
Cephalon

Completed

Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression

Obstructive Sleep Apnea | Major Depressive Disorder | Sleep Disorders | Dysthymic Disorder

United States
Cephalon

Completed

Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Narcolepsy | Excessive Daytime Sleepiness | Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)

United States
Cephalon

Completed

Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability (ERKENTNIS)

Pain | Cancer

Germany
Cephalon

Terminated

Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

Breakthrough Pain | Cancer Pain

Spain, Germany, France, Ireland, Italy, Poland, United Kingdom
Cephalon

Completed

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Narcolepsy

United States, Canada
Cephalon

Completed

Study of CEP-701 in Treatment of Prostate Cancer

Prostate Cancer

United States
Cephalon

Terminated

Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

Myeloma

United States
Cephalon

Completed

Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis

Psoriasis

United States
Cephalon

Completed

Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors

Solid Tumor

France, United Kingdom
Cephalon

Completed

OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Pain | Cancer

United States
Cephalon

Completed

Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness

Narcolepsy
Cephalon

Completed

A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment

Hepatic Impairment

United States
Cephalon

Completed

A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment

Renal Impairment

United States
Teva Branded Pharmaceutical Products R&D, Inc.
Sanofi

Recruiting

A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Crohn Disease | Colitis, Ulcerative

United States, Hungary, Poland, Czechia, Japan, Belgium, Spain, Bulgaria, France, Italy, Slovakia, Austria
Teva Branded Pharmaceutical Products R&D, Inc.
PPD

Completed

Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

Asthma

United States, Argentina, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Russian Federation, South Africa, Spain, Turkey, Ukraine
Cephalon

Terminated

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Depression

United States, Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Spain, Ukraine
Cephalon

Completed

Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States, Canada, Australia, Germany, Israel, Italy, New Zealand, Poland, Romania, Russian Federation, Spain, Sweden, Ukraine
Cephalon

Completed

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Depression

Spain, United States, Poland, Canada, South Africa, Argentina, Australia, Bulgaria, France, Ukraine
Cephalon

Completed

Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain

Pain

United States
Cephalon

Completed

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain

Chronic Low Back Pain

United States
Cephalon

Completed

Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Pain | Cancer

United States
Cephalon

Completed

SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)

Non-Hodgkin's Lymphoma

United States, Australia, Canada
Cephalon

Completed

Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain

Pain | Cancer | Sickle Cell Anemia | Severe Burns

United States, Canada, Puerto Rico

3

Subscribe